Literature DB >> 28273980

Risperidone Induced Granulomatous Mastitis Secondary to Hyperprolactinemia in a Non-Pregnant Woman-A Rare Case Report in a Bipolar Disorder.

Sadhana Holla1, M B Amberkar2, Avinash Kamath3, Meena Kumari Kamalkishore2, Balaji Ommurugan1.   

Abstract

Idiopathic granulomatous lesion is a rare entity of the breast seen in young-middle aged women. Diagnosis and management of granulomatous lesions with known aetiology does not impose major clinical problems. However, most often these lesions are undetected or unnoticed due to lack of timely diagnosis and inappropriate management, as primarily it is idiopathic. Hyperprolactinemia have been proposed as one of the mechanisms underlying the development of granulomatous lesions of the breast. We report a case of hyperprolactinemia due to risperidone therapy for bipolar mood disorder in a woman who eventually developed granulomatous mastitis. Histologically, the diagnosis was confirmed by the presence of granulomatous lesion and by ruling out other potential causes. In this case, raised prolactin was possibly an important factor which was secondary to risperidone therapy. However, idiopathic granulomatous mastitis could not be completely ruled out.

Entities:  

Keywords:  Anti-psychotics; Idiopathic; Non-infective; Trucut biopsy

Year:  2017        PMID: 28273980      PMCID: PMC5324425          DOI: 10.7860/JCDR/2017/20733.9278

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Granulomatous mastitis: a lesion clinically simulating carcinoma.

Authors:  E Kessler; Y Wolloch
Journal:  Am J Clin Pathol       Date:  1972-12       Impact factor: 2.493

2.  Feasibility of surgical management in patients with granulomatous mastitis.

Authors:  Oktar Asoglu; Vahit Ozmen; Hasan Karanlik; Mehtap Tunaci; Neslihan Cabioglu; Abdullah Igci; Unal Ersin Selcuk; Mustafa Kecer
Journal:  Breast J       Date:  2005 Mar-Apr       Impact factor: 2.431

Review 3.  Idiopathic granulomatous mastitis: an inflammatory breast condition with review of the literature.

Authors:  Michelle Mathew; Portia Siwawa; Subhasis Misra
Journal:  BMJ Case Rep       Date:  2015-03-04

4.  Idiopathic granulomatous mastitis associated with risperidone-induced hyperprolactinemia.

Authors:  Chih-Hsun Lin; Chih-Wei Hsu; Tang-Yi Tsao; Jason Chou
Journal:  Diagn Pathol       Date:  2012-01-05       Impact factor: 2.644

Review 5.  Aetiology of idiopathic granulomatous mastitis.

Authors:  Fatih Altintoprak; Taner Kivilcim; Orhan Veli Ozkan
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

6.  Idiopathic granulomatous lobular mastitis - report of 43 cases from iran; introducing a preliminary clinical practice guideline.

Authors:  Ramesh Omranipour; S-Farzad Mohammadi; Parisa Samimi
Journal:  Breast Care (Basel)       Date:  2013-12       Impact factor: 2.860

Review 7.  Prolactin and the skin: a dermatological perspective on an ancient pleiotropic peptide hormone.

Authors:  Kerstin Foitzik; Ewan A Langan; Ralf Paus
Journal:  J Invest Dermatol       Date:  2008-12-25       Impact factor: 8.551

8.  Adverse drug reaction and causality assessment scales.

Authors:  Syed Ahmed Zaki
Journal:  Lung India       Date:  2011-04

9.  An unusual case of bilateral granulomatous mastitis.

Authors:  C A Pistolese; R Di Trapano; V Girardi; E Costanzo; I Di Poce; G Simonetti
Journal:  Case Rep Radiol       Date:  2013-05-23

Review 10.  Hyperprolactinemia.

Authors:  Abha Majumdar; Nisha Sharma Mangal
Journal:  J Hum Reprod Sci       Date:  2013-07
View more
  2 in total

Review 1.  Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics.

Authors:  Samantha Alvarez-Herrera; Raúl Escamilla; Oscar Medina-Contreras; Ricardo Saracco; Yvonne Flores; Gabriela Hurtado-Alvarado; José Luis Maldonado-García; Enrique Becerril-Villanueva; Gilberto Pérez-Sánchez; Lenin Pavón
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-21       Impact factor: 5.555

Review 2.  Mastitis in Autoimmune Diseases: Review of the Literature, Diagnostic Pathway, and Pathophysiological Key Players.

Authors:  Radjiv Goulabchand; Assia Hafidi; Philippe Van de Perre; Ingrid Millet; Alexandre Thibault Jacques Maria; Jacques Morel; Alain Le Quellec; Hélène Perrochia; Philippe Guilpain
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.